SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001003642-18-000093
Filing Date
2018-05-10
Accepted
2018-05-10 16:11:22
Documents
92
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ipxl-03x31x2018x10q.htm 10-Q 1220611
2 EXHIBIT 31.1 ipxl-03x31x2018x10qxexx311.htm EX-31.1 13436
3 EXHIBIT 31.2 ipxl-03x31x2018x10qxexx312.htm EX-31.2 13415
4 EXHIBIT 32.1 ipxl-03x31x2018x10qxexx321.htm EX-32.1 8208
5 EXHIBIT 32.2 ipxl-03x31x2018x10qxexx322.htm EX-32.2 7060
  Complete submission text file 0001003642-18-000093.txt   8721393

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipxl-20180331.xml EX-101.INS 1872184
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ipxl-20180331.xsd EX-101.SCH 69542
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ipxl-20180331_cal.xml EX-101.CAL 93591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ipxl-20180331_def.xml EX-101.DEF 422913
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ipxl-20180331_lab.xml EX-101.LAB 909788
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ipxl-20180331_pre.xml EX-101.PRE 566786
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
Impax Laboratories, LLC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 18822616
SIC: 2834 Pharmaceutical Preparations